CNI

Investor's Guide to Canadian National Railway

Canadian National Railway shares fell by -2.1% during the day's afternoon session, and are now trading at a price of $106.96. Is it time to buy the dip? To better answer that question, it's essential to check if the market is valuing the company's shares fairly in terms of its earnings and equity levels.

a Very Low P/E Ratio but Trades Above Its Graham Number:

Canadian National Railway Company, together with its subsidiaries, engages in the rail, intermodal, trucking, and marine transportation and logistics business in Canada and the United States. The company belongs to the Industrials sector, which has an average price to earnings (P/E) ratio of 25.42 and an average price to book (P/B) ratio of 3.2. In contrast, Canadian National Railway has a trailing 12 month P/E ratio of 17.8 and a P/B ratio of 3.46.

Canadian National Railway has moved -10.1% over the last year compared to 31.8% for the S&P 500 — a difference of -41.9%. Canadian National Railway has a 52 week high of $134.02 and a 52 week low of $105.28.

EPS Trend Sustained Primarily by Reducing the Number of Shares Outstanding:

2015 2016 2017 2018 2019 2020
Revenue (M) $12,611 $12,037 $13,041 $14,321 $14,917 $13,819
Operating Margins 42% 44% 43% 38% 37% 35%
Net Margins 28% 30% 42% 30% 28% 26%
Net Income (M) $3,538 $3,640 $5,484 $4,328 $4,216 $3,562
Net Interest Expense (M) $439 $480 $481 $489 $538 $554
Depreciation & Amort. (M) $1,158 $1,225 $1,281 $1,327 $1,559 $1,583
Diluted Shares (M) 805 779 757 738 723 713
Earnings Per Share $4.39 $4.67 $7.24 $5.87 $5.83 $5.0
EPS Growth n/a 6.38% 55.03% -18.92% -0.68% -14.24%
Free Cash Flow (M) $2,434 $2,507 $2,843 $2,387 $2,058 $3,302
CAPEX (M) $2,706 $2,695 $2,673 $3,531 $3,865 $2,863
Total Debt (M) $8,985 $9,448 $10,670 $12,540 $13,662 $12,832
Net Debt / EBITDA 1.37 1.42 1.55 1.8 1.9 1.93
Current Ratio 0.72 0.7 0.55 0.78 0.66 0.95
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS